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                                                   ABSTRACT 
 
AIMS AND OBJECTIVES:To study the incidence , risk factors,maternal 
,perinatal morbidity and mortality of patients with 
placentalabruption.MATERIALS AND METHODS:A Prospective 
observational study;Studyperiod-oneyear,Studygroup:Patientsadmitted with 
clinical diagnoses of abruption with gestational age more than 28 weeks.,cases 
diagnosed retrospectively with retroplacentalclot.The maternal outcome in 
terms of anaemia,shock,DIC,renalfailure,postpartumhaemorrhageand death 
were evaluated.Perinatal outcome in terms of birth weight,Apgarscore,perinatal 
mortality were noted.RESULTS:Among 191 patients of antepartum 
haemorrhage the incidence of abruption was 0.76%(1 in132 
deliveries.Maximum incidence was between 33-36 weeks of gestation and in 
multiparae.Hypertension and Anaemia are significant risk factors with ODDS 
ratio of 10.64    and 5.941       respectively.Coagulation 
failure:23.7%;Hypovolemic shock:37.62%;Renal failure:3.96%;Postpartum 
haemorrhage:34.65% and Couvelaire uterus:5.94% of patients.There were 2 
maternal deaths in our study and the perinatal death rate 
was48%.CONCLUSION:Correction of anaemia and hypertension would help to 
reduce the incidence and early referrals to the teritiary care centres will decrease 
the maternal and perinatal mortality. 
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INTRODUCTION 
The term abruptio placentae refers to a condition when 
haemorrhage occurs as a result of premature separation of normally 
situated placenta. It is one of the obstetric emergencies posing a threat 
tomaternal and fetal life. 
 The present study is done to know the incidence, risk factors of 
this disorder in our institution as well as the impact of this disorder on 
maternal and fetal outcome. 
Though abruption is an obstetric emergency and a leading cause 
of perinatal morbidity and mortality the availability of diagnostic 
modalities like ultrasonagram has proved helpful in excluding other 
causes of ante partum haemorrhage like placenta previa and for timely 
management of the condition. Moreover the increased use of 
caesarean section and the better availability of haematological 
facilities has made a good impact in the recent studies. 
 All patients with diagnoses of abruption confirmed either 
clinically or by ultrasonagram or retrospectively following delivery 
were evaluated in our study and the required intervention was made to 
effect delivery either vaginally or by caesarean section by primary 
 2 
 
clinical assessment of the patient and simultaneous treatment of 
haemodynamic instability or coagulation abnormality was carried out. 
The data generated from this study would help to improve maternal 
and fetal morbidity and mortality by planning prompt management of 
future cases of placental abruption. 
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AIMS AND OBJECTIVES 
To study the incidence and risk factors of patients presenting 
with placental abruption. 
To study the outcome of patients with abruptio placentae in 
terms of maternal and perinatal morbidity and mortality. 
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REVIEW OF LITERATURE 
GENERAL ASPECTS: 
GENERAL ASPECTS: Third trimester bleeding is one of the most 
omnious complications of pregnancy and it complicates 3% of 
pregnancies. Third trimester obstetric haemorrhage seems to be one of 
the three leading causes of both maternal and perinatal morbidity and 
mortality. The obstetric causes of bleeding in third trimester being 
very hazardous has to be differentiated from the non obstetric causes. 
Causes of third trimester bleeding 
OBSTETRIC NON OBSTETRIC 
1.Bloody show 1.Cervicitis 
2.placentaprevia 2.Cervical polyp 
3.abruptio placenta 3.Cervical erosion 
4.vasaprevia 4.Vaginitis 
5.Disseminated intravascular 
Coagulation 
5.Genital tract trauma 
6.Uterine rupture 6.Vulval,vaginalvaricosities 
7.Marginal sinus bleeding  
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DEVELOPMENT OFTHE PLACENTA: 
The placenta is a remarkable organ performing many diverse 
functions including transport of gases and metabolites, immunological 
protection and production of steroid and protein harmones. 
The zygote after repeated mitotic divisions gets converted in to 
a blastocyst. The outer layer of the blastocyst is called trophoblast and 
the inner cell mass is called embryoblast. The blastocyst after 
embedding in to the endometrium, the trophoblast rapidly proliferates 
and differentiates in to outer syncitiotrophoblast and an inner 
cytotrophoblast. The primary, secondary and tertiary villi are formed 
by the syncitiotrophoblasts and the intervillous space is formed by 
cytotrophoblasts. Until the end of sixteenth week the placenta grows 
in thickness and circumference due to the growth of the chorionic villi 
and expansion of the intervillousspace. After that there is little 
increase in thickness but it increases circumferentially until term. The 
implanted placenta by nature separates during the third stage of labor 
by a multiphasic process. 
Abruptio placentae is the premature separation of a normally 
implanted placenta with haemorrhage in to the decidua basalis (Konje 
and Taylor2001)1. Antepartum haemorrhage complicates 2to5% of 
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pregnancies. Placenta previa and Abruptio placenta remain the two 
importantcauses of antepartum haemorrhage. 
HISTORICAL ASPECTS: 
The term abruption in Latin means “breaking away” which 
describes the process by which the placental attachment to the uterus 
is disrupted by haemorrhage. 
In 1609 Louis Bourgeois recognised the premature separation of 
placenta. DeLee and Coole in1848 coined the term ABRUPTIO 
PLACENTAE todenote sudden forcible separation of placenta from its 
normal site. In 1775, Edward Rigby of NORWICH made the first 
clinical differentiation between abruptio placentae and placenta previa. 
He also called abruptio placentae as accidental haemorrhage 
EPIDEMIOLOGY  
The overall incidence of abruptio placentae varies from 0.5 to 
1% (Ananth et al 1996; Baumannetal2000)3. Diagnoses is always 
clinical. 
A pathologist often quotes a higher incidence of them have an 
unremarkable obstetric history. (Faye Petersen etal2006)4. 
 7 
 
The incidence varies due to variable diagnostic criteria as well 
as the increased recognition of milder forms of this disorder. Although 
various studies report a higher incidence of abruption in older women 
and those with increased parity (Konje andTaylor2001)1. There is 
conflicting evidence about the relationship of age and parity and 
abruption (Kramer etal 1997)5. 
ETIOLOGY: 
The etiology is obscure but impaired placentation, placental 
insufficiency, uteroplacental underperfusion seem to be the underlying 
mechanisms 
IMMUNOLOGICAL: 
Immunological defects also may lead to an extensive 
inflammatory response with release of cytokines and result in shallow 
trophoblastic invasion, defective spiral artery remodeling, placental 
infarctions and thrombosis (Matthiesen et al1995)6 
In placental abruption there is no suppression of cell mediated 
immunity and upregulation of humoral immunity which occurs in a 
normal pregnancy. This leads to exaggerated immune rejection of the 
fetus, activation of fetal monocytes and release of inflammatory 
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agents. HLA-G levels which avoid fetal rejection are decreased in 
abruption. If the signalling between trophoblastic and NK cells is poor 
it causes defective trophoblastic invasion and spiral artery remodeling 
which ultimately leads to dysfunctional placenta, thromboses, 
infarction and a generalised inflammation in which systemic 
endothelial dysfunction is a component. Hence placental abruption 
may be due to dysfunctional placenta caused by defective maternal 
immune response to paternal antigens. (Baumann et al 2000) 
INFLAMMATION: 
There is an increase of neutrophils and macrophages in 
placentae of women with abruption. There is increased production of 
TNF ALPHA and IL-BETA1 that increase the production of Matrix 
metalloproteinases by trophoblasts and other cell types. Increased 
premature production of Matrix metlloproteinases may destroy the 
extracellular matrix and cell to cell interactions causing premature 
placental detachment. (Ananth et al 2006a) 
VASCULAR DISEASE: 
A placental growth factor deficiency and sFlt-1 excess results 
from placental hypoxia associated defective remodeling of spiral 
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arteries. This defective remodeling leads to high resistance flow and 
finally rupture of decidual arteries. 
PATHOGENESIS AND PATHOPHYSIOLOGY OF ABRUPTIO 
PLACENTA: 
Abruption is due to rupture of the decidual artery. The decidua 
is separated from the placenta by the accumulating blood. The 
collected blood when small in quantity may hardly produce any 
morbid pathological changes in the uterine wall or on the placenta. 
When the blood continues to dissect through the placental decidual 
interface it may lead to complete or near complete placental 
separation. After this the blood may escape through the potential space 
between chorion and decidua until it reaches the cervix. Blood may 
seep in to myometrium producing the so called COUVELAIRE 
UTERUS or reach the amniotic cavity producing blood stained 
amniotic fluid.  
COUVELAIRE UTERUS (UTEROPLACENTAL 
APOPLEXY): 
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It is a pathological condition first described by Couvelaire and 
is met with severe forms of abruption. There is massive intravasation 
of blood in to the myometrium up to the serous coat. The condition is 
diagnosed only on laparatomy. The uterus is of dark port wine colour 
.It   occurs initially at the cornu before spreading to other areas .Free 
blood may be present in the peritoneum or there may be a broad 
ligament haematoma. This myometrial haematoma rarely interferes 
with uterine contractions and hence it is not an indication per se for 
hysterectomy. 
HEPATIC AND RENAL CHANGES: 
In severe types of abruption placentae a fibrin knot which is a 
thrombotic lesion in the hepatic sinusoids has been described to be 
specific of abruptio placentae. 
In renal changes oliguria and anuria may develop due to acute 
tubular necrosis in milder forms of abruption and renal cortical 
necrosis in severe forms of abruption. 
RETROPLACENTAL HAEMOTOMA17: 
 It is a universal accompaniment of separation of placenta but is 
usually of little clinical significance. A fresh clot loosely adherent to 
the surface of a newly delivered placenta is usually seen if the placenta 
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is retained in utero some time after delivery but it is not the genuine 
retroplacental haematoma. If the placenta is not routinely seen many 
true retroplacental haematomas may be missed. Although many small 
lesions go unnoticed the large excavating retroplacental clot is readily 
apparent. Lesser degrees of indentations are produced by smaller 
lesions but the clot is usually firmly adherent to the maternal surface. 
 
LARGE RETROPLACENTAL CLOT ON THE 
MATERNAL SURFACE OF PLACENTA 
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The colour of the haematoma is a function of the age. They lie 
between the basal plate and underlying endometrium and they are 
considered to be dissecting haemorrhages of the decidua. They have 
features similar to that of an intervillous thrombus histologically. 
Recurrent small haemorrhages may give a laminated appearance the 
oldest clot being near the placental surface. 
Incidence of retroplacental clots is 5%.In known preeclamptics 
the associated abnormalities in decidual arterioles may be implicated. 
In otherwise normal pregnancies there is no clear indication of 
precipitating factors. 
The clinical importance of retroplacental haematoma is two 
fold. Firstly the extent to which placenta remains deprived of its 
maternal blood supply clearly determines the survival of the fetus. 
However in otherwise normal pregnancies majority of these lesions 
have a little impact on fetal outcome. Secondly large retroplacental 
haematomas might result in consumptive coagulopathy in the mother. 
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RISK FACTORS: 
AGE: 
The incidence of abruption increases with maternal age. In the 
First and Second Trimester Evaluation of Risk trial(FASTER TRIAL) 
women older than 40 years were 2.3 times at more risk of abruption 
than those at35 years or younger. In a study by Bryan M Hibbard there 
is an increased incidence with maternal age and patients over 35 years 
are twice as prone to abruption as patients under 25 years. The 
unadjusted risk of abruptio placentae for women over the age of 35 
years was 2.2 times the risk for women aged 19-34 years.       
(Williams et al) 
PARITY: 
Although Pritchard and colleagues (1991) reported the 
incidence of abruption to be higher in women of great parity, Toohey 
and associates (1995) did not find this. HibbardBM and JEFFCOATE 
TNA30 in their studies found an association between high parity and 
abruption  
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NUTRITION: 
Folic acid deficiency seems to be an important factor in etiology 
of abruptio placentae. The possible association between folic acid 
deficiency and abruption is proved by bone marrow biopsy studies 
showing megaloblastic erythropoiesis. (Hourihana et al) 
HYPERTENSIVE DISORDERS OF PREGNANCY: 
The most common condition associated with abruption seems to 
be some form of hypertension (gestational hypertension, chronic 
hypertension, preeclampsia). Sibai and coworkers (1998) reported that 
1.5% of pregnant women with chronic hypertension suffered placental 
abruption. Ananth and associates (2007) reported a2.4fold increased 
incidence of placental abruption with chronic hypertension and this 
was increased further if there was superimposed preeclampsia or 
IUGR. The severity of hypertension does not correlate with the 
incidence of abruption. (Witlin and colleagues Zetterstrom and 
coworkers 2005). 
PREMATURE RUPTURE OF MEMBRANES: 
There is an increased frequency of placental abruption in 
patients with early rupture of membranes. The incidence was 13% 
when premature rupture of membranes occured during gestational age 
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29-32 weeks. (Holmgren Paetal1997 Histological chorioamnionitis is 
associated with increased incidence of placental abruption and this 
association is dependent on its severity. (Nath et al 2007)25 
SMOKING AND COCAINE ABUSE: 
Smoking increases the overall risk of abruptioplacentae. 
According to a prospective cohort study the increase is by40% for 
each year of smoking prior to pregnancy. The rate of abruption has 
been reported to be13-35% in patients who abuse cocaine and seems 
to be dose dependent. 
TRAUMA: 
Blunt abdominal trauma or rapid decompression of uterus may 
cause shearing of placenta due to sudden stretching or contraction of 
uterine wall. Severe maternal trauma has been associated with a six 
fold risk of abruption. 
EXTERNAL CEPHALIC VERSION: 
When external cephalic version was a common practice 
abruption was a well known complication of it, especially when 
version was performed under anaesthesia. The incidence of abruption 
is said to be 2 to9% according to Savona Ventura (1986) who quotes 4 
series of cases. The practice of version is now being revived and with 
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the addition of to colytic drugs the complication rates are reported to 
be low (Lancet Leader 1984) 
THROMBOPHILIAS: 
The association between placental abruption and the maternal 
thrombophilias supports the fact that abruption is a final acute clinical 
presentation of a chronic placental disease. (WENDY LKINZER etal) 
MULTIPLE PREGNANCY: 
The risk of placental abruption is increased 2-3 fold in multiple 
gestations (Salihu et al 200520, Ananth et al2001). In patients with 
twin gestation associated with placental abruption the risk of preterm 
birth or SGA is higher. 
PLACENTA PREVIA: 
About 10% women with placenta previa may have placenta 
previacoexistently. (Konje and taylor2001)1 
OTHERS: 
First trimester ultrasound examination showing a subchorionic 
or retroplacental haematomaincreases the subsequent placental 
abruption risk to 6-7 fold. (Balletal1996, NAGY et al 2003) 
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When the membranes rupture as in the case of poly hydramnios 
there is asudden decompression of the uterus .This leads to the 
reduction in uterine volume and a corresponding loss of surface area 
and as a result the placenta sheers off. 
Abruption has been reported as a result of snakebite (Zugaib et 
al 1985) but has not been reported as a result of anticoagulant therapy. 
(Howell et al 19838) 
Uterine malformations may lead to poor decidualisation and 
placentation. The contractility of a malformed uterus may lead to 
uncoordinated uterine action resulting in increased risk of placental 
abruption (Dabrashrafi et al1999).The risk of abruption is increased in 
patients with lower segment uterine scar due to impaired placental 
attachment.(Rasmussen et al199916; Lydon Rochelle et al 2001) 
RECCURRENT PLACENTAL ABRUPTION: 
Ina women with a previous history of abruption there is a7-20 
fold risk in a subsequent pregnancy (Karegard and Genser 198611, 
Ananth et al19963) 
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PREDICTORS: 
BIOCHEMICAL MARKERS: 
Unexplained second trimester elevation in MSAFP may be 
associated with subsequent adverse obstetric outcome including 
placental abruption. (Dugoff et al200512, Smith et al2006).This is due 
to chronic villitis and vascular thromboses or infarction (Salafia et 
al198813).AFP levels >2.0MoM were detected in 17% of pregnancies 
with subsequent placental abruption (Finish study2002). Though 
MSAFP levels is a good marker for placental abruption it has not been 
used for this purpose widely in clinical practise. High levels of 
maternal serum beta hcg have been linked to placental abruption.   
(Liu et al1999).Decreased placental perfusion may lead to increased 
beta hcg. 
Low levels of PAPP-A detected in the first trimester (29% at 
lowest 5th percentile and 43%at lowest 10th percentile) have been 
linked with placental abruption (Pilalis et al200714). Proangiogenic 
placental growth factor (PIGF) and antiangiogenic soluble - fms like 
tyrosine kinase-1(sflt-1) are the regulators of angiogenesis in 
pregnancy. Increased levels of sflt1/PIG F ratios at21-32 weeks of 
gestation preceded subsequent placental abrubtion only in women who 
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has developed preeclampsia or PIH (Signnora et al 200629) 
Fibronectin produced in the endothelial cell seems to be 
increased with placental abruption (Kanayama and Terao1992). 
 Levels of thrombomodulin which is a marker of endothelial 
cell damage may be increased with placental abruption (Magriples et 
al 1999). 
 D - dimer a by product of clot analysis may be used in early 
diagnoses of abruption (Nolan et al1993) 
Uterine artery flow measurement: 
High uterine artery pulsatility index at11-14 weeks or notching 
of the uterine artery waveform at 20-24 gestational weeks also may 
predict subsequent placental abruption (Pilalis et al200714) but these 
methods have not been accepted universally in the prediction of 
abruption. 
FAMILY HISTORY: 
5% of women with abruption may have first degree relatives 
with abruption (Lindquist and Happach 200610). 
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CLINICAL PRESENTATION: 
The clinical presentation varies from one patient to another. 
Vaginal bleeding, painabdomen, uterine tenderness, loss of fetal 
movements seem to be the classic symptoms. All these symptoms 
need not be present and asymptomatic presentation does not exclude 
placental abruption. 
Placental abruption may be revealed or concealed. In the 
revealed type blood tracks between the membranes and the decidua 
escaping through the vagina. The less common concealed type occurs 
when blood collects behind the placenta without any external bleeding 
(Oyelese and Ananth20062) 
 
 
 
 
 
 
A. Revealed type B. Concealed type 
 21 
 
Four grades of placental abruption based on 
PAGE'S CLASSIFICATION: 
Grade0 : An asymptomatic retroplacental clot seen after  
   placental delivery. 
Grade1 : Present with vaginal bleeding and mild uterine  
   tenderness. 
Grade2 : Vaginal bleeding may or may not be present but  
   placental separation is significant enough to cause  
   fetal compromise. 
Grade3 : Vaginal bleeding may be moderate or severe but  
   there may be significant maternal complications  
   along with late stage of fetal compromise or fetal 
   death. 
Geofrrey Sher (1978) proposed a clinical grading system 
Grade1 : Diagnoses is made retrospectively by seeing a  
   retroplacental clot. 
Grade2 : Cases in which the fetus is alive. The retroplacental 
   clot volume is usually 150 to 500gms. 
Grade3 : Features of Grade2 but fetal demise is confirmed. 
   Grade 3 is further subdivided based on A) presence 
   or B) absence of coagulopathy. 
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 Vaginal bleeding is present in 70-80%of placental abruption 
though its amount poorly correlates with the degree of abruption. 
Uterine tendernss or pain is present in 66%. Hypertonic uterine 
contractions may be seen in 34% cases. Abdominal pain is less 
common in posterior placentations. 
DIFFERENTIAL DIAGNOSES IN CASES OF CONCEALED 
OR MIXED TYPES: 
1. Rupture uterus 
2. Acutehydramnios 
3. Rectus sheath haematoma 
4. Appendicular or intestinal perforation 
5. volvulus 
6. Twisted ovarian tumor 
7. Tonic uterine contraction 
8. Red degeneration of fibroid. 
 
Points in favour of concealed abruption: 
1. Shock out of proportion to external bleeding 
2. Unexplainedanaemia with tense uterus 
3. presence of severe preeclampsia 
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4. uterus may be tense tender  
5. absent fetal heart 
6. oliguria 
7. coagulopathies 
 
ULTASONAGRAM IN ABRUPTION: 
Ultrasound abdomen is done 
1. to rule out placenta previa 
2. to reveal the state of fetus and degree of placental separation 
 
In acute phase of abruption the haematoma appears hyperechoic 
to isoechoic when compared to placenta. On resolution the haematoma 
becomes hypoechoic within 1 week and sonoluscent within 2 weeks 
(Nyberget al1987). 
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A. Normal Placenta B, C Large Retro Placental Abruption            
D. Thickened Placenta with Heterogenous Appearance, Arrow Heads 
Show Areas of Haemorrhage. 
Although there is marked improvement in, the diagnoses of 
abruption was correct only in 25%. (Glantz and Purnell200231). When 
a clot was visualised by USG, the positive predictive value of 
abruption was 88%. 
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Jello Sign: 
The placenta may jiggle when sudden pressure is applied with 
transducer. However the ultrasound though inaccurate in diagnoses of 
abruption may be very helpful in excluding a placenta previa. 
CARDIOTOCOGRAPHIC CHANGES: 
Placental abruption may be associated with a variety of CTG 
patterns and this includes repetitive, late and variable decelerations, 
decreased beat to beat variability, bradycardia or sinusoidal fetal heart 
rate pattern (Oyelese andAnanth2006)2 
 
CTG OF A DEAD FETUS WITH UTERUS SHOWING 
HYPERTONIC CONTRACTIONS (SAWTOOTH PATTERN) 
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MATERNAL MORBIDITY: 
The maternal complications primarily depend on the severity of 
abruption. They include haemorhage and need for blood transfusions, 
coagulopathy, renal failure and hypovolemic shock, hysterectomy and 
less commonly maternal death. In cases of abruption severe enough to 
cause death of the fetus DIC sets in. Hypovolemiaor DIC may be a 
forerunner of acute renal failure.  
HAEMORRHAGIC SHOCK:  
There is significant loss of blood volume, either revealed 
vaginally or concealed within the uterus. 
In pregnancy the increased blood volume and increased levels 
of coagulation factors such as fibrinogen and factor 7, 8 and 10  
provide protection against haemorrhage. But when there is more than 
25% loss of total blood volume, rapid haemodynamic deteroriation 
occurs. 
When there is continuous bleeding and development of 
anaerobic metabolism with acidosis, there may be development of left 
ventricular failure and thereafter irreversible shock. 
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DISSEMINATED INTRAVASCULAR COAGULATION: 
 This is another common complication met with severe grades 
of abruptions associated with fetal death. In abruption placentae the 
release of procoagulant substances lead to release of tissue 
thromboplastins (from placental injury) in to the maternal circulation. 
Due to the hypovolemia and hypoxia induced endothelial 
response there is white cell activation and production of 
proinflammatory cytokines and oxygen free radicals. These increase 
the oxidative stress and promote lipid peroxidation once antioxidant 
mechanisms are saturated. So there is loss of vascular integrity and 
hence increased vascular permeability. 
The thromboplstins and the endothelial damage lead to 
widespread activation of coagulation cascade. If this goes unchecked, 
there is rapid consumption of coagulation factors and platelets with 
deposition of fibrin in microcirculation and thrombus formation in the 
placental surface. This leads to defibrination, thrombocytopenia and 
hemostatic failure. Disseminated intravascular coagulation also 
stimulates fibrinolysis and the resultant fibrin degradation products 
interferes with clot formation producing haemorrhage and also has a 
negative effect on cardiac function. The diagnoses of disseminated 
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intravascular coagulation is based on a combination of clinical and 
laboratory diagnoses. Bleeding can occur at venepuncture sites, gums, 
nose, rectum etc. Platelet counts and coagulation tests are abnormal 
.As more than 50% clotting factors must be consumed before the 
coagulation tests become abnormal, these tests become insensitive. As 
fibrinogen levels are increased in normal pregnancy, even low normal 
levels should be of concern. Fibrin degradation products including    
D-dimer are measured in the circulation and their abnormal levels help 
to confirm the presence of coagulopathy. 
RHESUS ISOIMMUNISATION: 
There may be a significant amount of fetomaternal 
haemorrhage. So it is advisable for all rhesus negative women with 
abruptio  placentae to undergo a kleihauverbetke testto determine the 
correct dose of ANTI-D Immunoglobulin.  
Maternal mortality however has decreased in the past few years 
due to increased maternal health care facilities. Also women with a 
history of placental abruption are less likely to become pregnant again 
when compared to control cohorts(Rasmussen et al1999)16. 
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A study of long term effect of placental abruption on maternal 
health (Ray et al2005)32 shows a risk of development of premature 
cardiovascular disease in 70% of these women. But the cause remains 
unclear. 
PERINATAL MORBIDITY AND MORTALITY: 
Perinatal morbidity includes low birth weight, preterm 
deliveries, birthasphyxia, stillbirth, intrauterinedeath, neonataldeaths. 
Here also the fetal survival depends on the grade of abruption as well 
as the gestational age. 
If more than 50% of placental surface is involved fetal death 
invariably occurs. The perinatal mortality also depends on the 
prematurity of the fetus and the neonatal facilities available. Both 
spontaneous and iatrogenic preterm deliveries are common in 
placental abruption. 
Fetal growth restriction is so well associated with abruption, 
that it could be taken as a single marker for risk of abruption (Ananth 
and Wilcox 2001)24.Even congenital fetal malformations are 
approximately two times higher than in general population (Konje and 
Taylor20011).The cause behind this remains unclear. Low Apgar 
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scores and cord blood pH values are due to maternal hypoxia (Spinillo 
et al 1993)9.The risk of birth asphyxia is 3.7 fold. Long term risk of 
neonates born to mothers with placental abruption are development of 
cystic periventricular leukomalacia or intra ventricular haemorrhage. 
These neural defects increase with prematurity and low birth weight 
(Spinillo etal1993)9 
GENERAL MANAGEMENT: 
A rapid clinical assessment should bedone in women presenting 
with antepartum haemorrhage whether urgent intervention is required 
to manage maternal or fetal compromise. In women presenting with 
massive haemorrhage resuscitation should be started immediately 
since mother is the priority and should be stabilised prior to 
establishing the fetal condition. Meanwhile blood should be collected 
for investigations to identify complications. 
The investigations may include: 
The investigations may include  
Blood Hb% 
Platelet count 
Leucocyte count 
Peripheral blood smear 
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Blood for grouping and typing  
Bleeding and clotting time 
Clot observation and retraction time 
Prothrombin time 
Activated partial thromboplastin time 
Serum fibrinogen level 
Fibrin degradation product levels 
D-dimer levels 
Liver function tests 
Renal function tests 
Serum electrolytes 
Arterial blood gas analysis 
Kleivauher Betketest (if available) 
 
OBSTETRIC MANAGEMENT: 
The clinical presentation of placental abruption being variable, 
the obstetrical management is individualised on a case by case basis. 
The presentation, gestaional age and the degree of maternal and fetal 
compromise decides the management. In cases of abruption at or near 
term with a live fetus, prompt delivery is indicated. If there is fetal 
compromise, and delivery is not imminent, Caesarean section should 
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be performed. When the maternal and fetal conditions are reassuring 
vaginal delivery may be reasonable. 
RUPTURING THE MEMBRANES AND HASTENING 
DELIVERY: 
The main purose of doing an amniotomy is to hasten the onset 
of labour and by encouraging uterine contractions, to reduce uterine 
bleeding. It is effective and useful in most cases but seems to be 
dangerous in a few. If the uterus has become atonic as happens rarely, 
reduction of intrauterine pressure encourages further bleeding which 
fills the space. An intravenous infusion of oxytocin should always be 
started.  
If patient is in established labor it may be allowed to progress in 
these conditions. On the other hand induction of labor may be planned 
if the labor has not been established. There should be close monitoring 
of both mother and fetus and when fetal heart rate becomes 
nonreassuring, caesarean section is indicated.  
In patients with severe placental abruption resulting in 
intrauterine fetal death, if the mother is stable, it is reasonable to allow 
for a vaginal delivery in the absence of any obstetric indications. 
Labour usually progresses rapidly because of viguorous uterine 
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contractions and an amniotomy may speed up delivery. When labor 
does not progress rapidly or in case of obstetrical indications like 
cephalopelvic disproportion, a scarred uterus or a fetal 
malpresentation. 
Caesarean delivery may be performed to avoid worsening of 
coagulopathy. But stabilisation of the patient and correction of any 
coagulation defects is very much essential during surgery. The patient 
should be closely monitored paying attention to vital signs, amount of 
blood loss, urine output. Uterus may remain hypotonic necessitating 
emergency hysterectomy. There should be a high index of suspicions 
of preeclampsia in patients with abruption because this may be 
masked by hypovolemia. 
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MANAGEMENT OF MATERNAL COMPLICATIONS: 
Haemorrhagic shock is a major complication of abruption. 
Hypovolemia should be corrected early. Since there may be a greater 
degree of vasospasm blood pressure may not be a good guide to assess 
shock. So regardless of the patient’s general condition atleast one litre 
of blood should be transfused. Central venous pressure is the best 
guide to monitor the patient .Haematocrit should be atleast 30% and 
urine output more than 30 ml per hour. 
Disseminated intravascular coagulation is due to release of 
tissue thromboplastin in placental abruption leading to consumptive 
coagulopathy. Whole blood transfusion replenishes not only the 
fibrinogen but also other procoagulants. Fresh frozen plasma helps in 
the administration of fibrinogen, a necessary procoagulant. Prompt 
replacement of blood volume and coagulation factors helps a lot in the 
management of these coagulation disorders. There is no role of 
heparin or anticoagulants in disseminated intravascular coagulation 
caused by abruption.  
Steps for immediate delivery of the fetus should be taken that 
would help to improve the haemostatic competence in vast majority of 
cases. Usually the coagulopathy settles immediately after delivery and 
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there is no clinically evident coagulopathy 12 after the delivery. 
Renal failure in its early phase can be corrected in most cases of 
abruption by volume replacement .But however in its late phases the 
help of a nephrologist is needed. 
 
EXPECTANT MANAGEMENT: 
In case of preterm gestational ages when there is minimal 
abruption evidenced by ultrasound, there is a role of conservative 
management. But this should be individualised on a case to case basis. 
These patients usually present with a small vaginal bleed and a 
localised area of uterine tenderness or an ultrasound evidence of 
minimal separation of placenta. In such circumstances there is 
something gained from allowing the pregnancy to continue but the 
decision to terminate will depend on the length of gestation, whether 
there was a previous episode the state of fetus and the extent of 
placental separation. 
Abruption in a posteriorly situated placenta is dangerous 
because the only symptom being backache and also the placenta is out 
of reach.However innocuous the incidence of abruption seems to be 
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there is some damage to the integrity and function of placenta. And 
these patients need an extremely close monitoring because of a 
significant risk of fetal death at any period of time. Initial 
hospitalisation for further evaluation and fetal wellbeing is necessary 
and serial ultrasonagrams may be needed to evaluate progression or 
regression of abruption. 
PREVENTION OF ABRUPTIO PLACENTAE: 
It aims at prevention of risk factors likely to cause abruption, early 
detection of anaemia in the antenatal period and its correction and 
prompt identification and commencement of therapy to minimise 
grave complications namely shock, coagulopathy, renalfailure. 
Prevention of factors likely to cause placental separation are:  
1. Early diagnoses and treatment of preeclampsia and other 
hypertensive disorders of pregnancy. 
2. Avoidance of sudden rupture of membranes. 
3. Avoidance of trauma especially forceful external cephalic 
version. 
4. Regular intake of folic acid in early pregnancy. 
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MANAGEMENT OF A SUBSEQUEUENT PREGNANCY: 
These women are at a ten fold risk of having an abruption in the next 
pregnancy. They are also at increased risk of other pregnancy 
outcomes like preterm birth and preeclampsia. Some 
recommendations are possible in this women. Women who smoke 
tobacco or use cocaine should be encouraged to quit before next 
pregnancy. Hypertension should be controlled well before the next 
pregnancy. It is reasonable to treat women with inherited 
thrombophilias with thrombophylaxis although no clear benefit has 
been demonstrated. Because patients with abruption have an increased 
risk of impaired uteroplacental perfusion it is reasonable to do serial 
scans during the second half of subsequent pregnancy. 
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MATERIALS AND METHODS 
A prospective observational clinical study was carried out in our 
institution from Oct’12 to Sept’13 to determine the incidence, risk 
factors, maternal and perinatal outcome in patients presenting with 
abruption placentae. Study group consists of patients admitted to our 
labour room with clinical diagnosis of abruption and gestational age 
more than 28weeks. Cases diagnosed retrospectively with 
retroplacental clots were included in this study. 
INCLUSION CRITERIA: 
Pregnant women with gestational age more than 28 weeks with 
complaints of bleeding per vaginum. 
Patients with retroplacental clots diagnosed retrospectively. 
EXCLUSION CRITERIA: 
Patients with atypical signs and symptoms were excluded from 
the study after their delivery if there was no clinical evidence of 
abruption. 
A detailed history of the patient including the obstetric history 
was taken. A good clinical examination and an ultrasound examination 
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were done for the patients to arrive at a diagnoses and the patients 
diagnosed to have placental abruption were followed up for maternal 
and fetal outcome. 
Risk factors for abruption were analysed by the following 
statistical methods in the patients presenting with abruption. 
1. Chi square test, 
2. Fisher exact test 
Investigations including coagulation profile and the renal 
function tests were done to identify complications.  
The grade of abruption presenting in the patient was identified 
and the severity was correlated with the maternal morbidity and 
mortality as well as fetal outcome in terms of intrauterine fetal death, 
stillbirths, neonatal admissions and neonatal deaths. 
 The fetal outcome was also measured on the basis of route of 
delivery and also the birth weight. 
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RESULTS OF THE STUDY 
TABLE I 
Total No. of Deliveries in study period : 13239 
 Incidence % 
Antepartum 
Haemorrhage 
191 1.44% 
Abruptio Placentae 101 0.76% 
Placenta Previa 78 0.5% 
Others 12 0.09% 
 
The total number of deliveries in the study period was 13239. 
.Among these patients presenting with antepartum haemorrhage 
accounted for 191caseswith an incidence rate of 1.44%.The two main 
causes of antepartum haemorrhage are Placenta previa and placental 
abruption. In our study placental abruption accounted for 101 cases 
making up an incidence of 0.76% i.e,1 in132 deliveries. 
 The number of patients presenting with Placenta previa
with an incidence of 0.5%.The remaining patients
haemorrhage were12 and make up an incidence of0.09 %.
 
40.84%
6.28%
DISTRIBUTION OF ANTEPARTUM 
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When the age was analysed the highest incidence was among 
21-25 years accounting
abruption occurred was 18 years and the highest age was 38 years.
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21-25 years
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TABLE II 
PLACENTAL 
ABRUPTION 
Incidence % 
7 6.93%
52 51.48%
35 34.65%
6 5.94%
1 0.99%
  for 52%.The youngest age at which 
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Parity 
Primi 
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The incidence of abruption was seen to be 
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TABLE III 
=101 CASES)
 
Incidence % 
39 38.61%
62 61.38%
highest among multipara.
 
38.61%
 
 
 
 
 
Primi
Multi
 BASED ON ANTENATAL BOOKING STATUS
 
Booked 
Unbooked 
 
In our study the nu
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ANTENATAL BOOKING STATUS
44 
TABLE IV 
 
No. of Women % 
95 94.05%
6 5.94%
mber of booked women were 94.05%
 
94.05%
5.94%
Booked
Unbooked
 
 
 
 
 BASED ON GESTATIONAL AGE
 
Gestational Age In 
Weeks 
28-32 weeks 
33-36 weeks 
37 Weeks & Above 
 
In our study there was a higher incidence of
in women belonging to gestational age of 33 to36 weeks.
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25.00%
50.00%
28-32 weeks
26.73%
Based on Gestational Age
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TABLE V 
 
No. of Patients 
(n=101) % 
27 26.73%
47 46.53%
27 26.73%
 placental abruption 
 
 
33-36 weeks
37 Weeks & 
Above
46.53%
26.73%
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TABLE VI 
DISTRIBUTION BASED ON PRESENTING SIGNS AND 
SYMPTOMS 
 
Signs and Symptoms No. of Patients % 
Vaginal Bleeding 82 81.18% 
Pain Abdomen 88 87.12% 
Tense, Tender Uterus 73 72.27% 
Absent Fetal Heart 37 36.63% 
Shock 38 37.62% 
Hypertension 62 61.30% 
 
The clinical presentation was either single or a combination of above 
symptoms and signs. The most common presenting sign was vaginal 
bleeding, followed by pain abdomen and a tense, tender uterus. 
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TABLE VII 
DISTRIBUTION BASED ON RISK FACTORS 
 
Hypertensive disorders of pregnancy in the form of pregnancy 
induced hypertension accounted for 56 cases while 6 cases were due 
to chronic hypertension 
.From the above table we infer that anaemia and hypertension 
are the two significant associated factors. 
1. The patients with anaemia are having ten times risk for 
developing abruption,(ODDS RATIO =10.64) 
  
Risk Factors Patients 
withAbruption 
Other patients 
with APH Tests P-value 
Hypertensive 
Disorders 
62 
(61.30%) 19 
Chi-square 
(p<0.0000001) 
significant 
Anaemia 76 (75.24%) 20 
Chi-square 
(p<0.0000001) 
significant 
Trauma 2 (1.98%) 0 
Fisher Exact 
(p=0.5566) 
Not 
significant 
Hydramnios 4 (3.96%) 1 
Fisher Exact 
(p=0.4446) 
Not 
significant 
Short Cord 3 (2.97%) 1 
Fisher Exact 
(p=0.7103) 
Not 
significant 
Multiple 
Pregnancy 
2 
(1.98%) 2 
Fisher Exact 
(p>0.9999) 
Not 
significant 
Prev. H\o 
Abruption 
3 
(2.97%) - - - 
Uterine 
Anomalies - - - - 
Smoking and 
Cocaine - - - - 
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2. The patients with hypertension have five times more risk of 
developing abruption.(ODDS RATIO=5.941) 
There were 2 cases of trauma abdomen which was due to a fall 
from a height. There were 4 cases of hydramnios. Short umblical cord 
was recognised postnatally in 3 cases of abruption. There were 2 cases 
of twin gestation in the study group. No significant anomalies could be 
made out in the study group. Three of the women gave a previous 
history of abruption of which had a short interpregnancy interval of 
one year. Drug abuse history was not obtained from any of the women 
in the study group. 
  
 DISTRIBUTION BASED ON GRADES OF ABRUPTION
Grades 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
Grades of abruption were based on Page’s classification.
3 abruption which is a severe grade is seen in 37
patients had invariably fetal demise. 
maternal complications also.
 
36.63%
DISTRIBUTION BASED ON GRADES 
OF ABRUPTION
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TABLE VIII 
No. of Patients % 
21 20.79%
14 13.86%
29 28.71%
37 36.63%
patients.These 
Some of them developed 
 
 
20.79%
13.86%
28.71%
Grade 0
Grade 1
Grade 2
Grade 3
 
 
 
 
 
 Grade 
 
 DISTRIBUTION BASED ON TYPES OF ABRUPTION
Distribution Based on Types of Abruption
Types 
Concealed 
Revealed 
Mixed 
 
The maximum 
with onely revealed type of abruption was only 2.97%.
 
0.00%
50.00%
100.00%
Concealed
20.79%
Distribution Based on Types of Abruption
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TABLE IX 
 
No. of Patients % 
21 20.79%
3 2.97%
77 76.23%
number of cases were in the mixed type. 
 
 
Revealed
Mixed
2.97%
76.23%
 
 
 
 
Patients 
 
 DISTRIBUTION BASED ON FETAL PRESENTATION
Presentation 
Cephalic 
Breech 
Transverse Lie 
 
Majority of cases were in cephalic presentation.
cephalic presentations were due to prematurity.
 
13.86%
DISTRIBUTION BASED ON FETAL 
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TABLE X 
No. of Patients % 
85 84.15%
14 13.86%
2 1.98%
 The non 
 
 
84.15%
1.98%
PRESENTATION
Cephalic Breech Transverse Lie
 
 
 
 
 DISTRIBUTION BASED ON MEMBRANE STATUS
Status of Membrane 
on Admission 
Absent Membranes 
Intact Membranes 
 
Most of them had intact membranes on admission
 
DISTRIBUTION BASED ON STATUS OF 
Absent Membranes
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TABLE XI 
No. of Patients % 
12 11.88%
89 88.11%
 
 
 
11.88%
88.11%
MEMBRANES
Intact Membranes
 
 
 
 
 59%
DISTRIBUTION BASED ON MODE OF 
DISTRIBUTION BASED ON MODE OF DELIVERY
Mode of Delivery 
Vaginal Delivery 
Caesarean 
 
There were 100 deliveries 
death occurred antenatally with fetus in utero.
deliveries there were 41 vaginal deliveries
Out of the 41 vaginal deliveries Grade 0 abruption diagnosed 
retrospectively constituted 18
53 
41%
DELIVERY
Vaginal Delivery
Caesarean
TABLE XII 
No. of Patients 
(n=100) % 
41 41%
59 59%
among 101 cases. One maternal 
 Among the 100 
 and 59 caesarean deliveries. 
 cases. 
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TABLE XIII 
BREAK UP OF THE COURSE OF VAGINAL 
DELIVERIES IS SHOWN IN THE TABLE BELOW 
Nature of Progress 
of Vaginal Delivery 
Vaginal Deliveries 
(n=23) % 
Spontaneous Nil Nil 
ARM 3 13.04% 
ARM + Oxytocin 15 65.21% 
Prostaglandin 
Induction 3 13.04% 
 
Among 41 vaginal deliveries excluding the18 Grade 0 cases the 
progress of labour in remaining 23 were studied. Three of them were 
delivered by amniotomy alone, fifteen of them needed an oxytocin 
infusion .Three of them needed an induction with misoprostol. 
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TABLE XIV 
 
BREAKUP OF CAESAREAN SECTION EXCLUDING GRADE 
‘0’ CASES (3 CASES) 
 
 
No. of Patients 
(n=56) % 
ARM + Oxytocin 
followed by LSCS 20 35.71% 
Direct LSCS 36 64.28% 
 
Excluding the 3Grade 0 cases, out of the remining 56 cases 36 
patients had direct caesarean section without attempting for a vaginal 
delivery. Most of them were with a history of previous LSCS or grade 
2 abruptions with fetal distress.  
The remaining 20 patients had a Caesarean done after an 
attempt for vaginal delivery with amniotomy and oxytocin  
 DISTRIBUTION BASED ON ABRUPTION DELIVERY 
Abruption Delivery 
Interval 
< 2 hrs 
2-4 hrs 
5-8 hrs 
> 8 hrs 
 
Most of the patients were delivered with in 2
abruption. 
17.82%
DISTRIBUTION BASED ON ABRUPTION 
56 
TABLE XV 
 
INTERVAL 
No. of Women 
(n=80) % 
5 6.25%
54 57.42%
17 21.25%
- 
-4 hours of 
 
5%
57.42%
0%
DELIVERY INTERVAL
 
 
 
- 
 
< 2 hrs
2-4 hrs
5-8 hrs
> 8 hrs
 0%
25%
50%
75%
< 150 gms
21%
Distribution Based on Weight of 
Retroplacental Clots
DISTRIBUTION BASED ON WEIGHT OF 
RETROPLACENTAL CLOTS
Weight of RP Clots 
< 150 gms 
150-500 gms 
> 500 gms 
 
Majority of patients had retroplacental clots weighing 
500gms. 
57 
150-500 gms
> 500 gms
63%
16%
TABLE XVI 
 
Total No. of Cases 
(n=100) % 
21 21%
63 63%
16 16%
 
 
 
150-
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TABLE XVII 
DISTRIBUTION BASED ON MATERNAL COMPLICATIONS 
OF ABRUPTION 
Maternal 
Complications  
Total No. of Cases 
(n=101) % 
Hypovolemic Shock 38 37.62% 
Coagulation Failure 24 23.76% 
Renal Failure 4 3.96% 
Post Partum 
Haemorrhage  35 34.65 
Couvelaire Uterus 6 5.94% 
 
Hypovolemic shock was the major complication noted. It was 
corrected with crystalloids, whole blood, transfusion. Coagulation 
failure detected by our coagulation tests was corrected by fresh frozen 
plasma as well as whole blood transfusions. Renal failure was 
corrected by correction of depleted intravascular volume and in none 
of them a haemodialysis was necessary. 
Postpartum haemorrhage was medically managed in most of 
cases. Only 1 patient had a caesarean hysterectomy. In patients who 
had a caesarean delivery there were 6 cases of couvelaire uterus. 
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TABLE XVIII 
PERINATAL MORTALITY IN VAGINAL & CAESAREAN 
DELIVERIES 
Mode of Delivery Alive Dead Total Perinatal Mortality 
Vaginal Delivery (41) 24 17 
50 
Caesarean (59) 28(1T) 33(1T) 
 
Tables 19 and 20 give a break up for fetal fate based on fetal 
weight and route of delivery. 
TABLE XIX 
PERINATAL MORTALITY IN VAGINAL DELIVERY BASED 
ON BIRTH WEIGHT 
Birth 
Weight <1 kg 
1000 – 
1499 
gms 
1500 – 
2499 
gms 
> 
2500gm
s 
 
Total 
Perinatal 
Mortality 
Infants alive 
on admission - 1 7 17 25 
15 
IUFD 2 1 7 3 13 
Still Birth - 1 - - 1 
Neonatal 
Death - 1 - - 1 
Infants 
Survived - - 7 17 24 
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TABLE XX 
PERINATAL MORTALITY IN CESAREANDELIVERY 
BASED ON BIRTH WEIGHT 
Birth 
Weight <1 kg 
1000 – 
1499 
gms 
1500 – 
2499 
gms 
> 
2500gms 
 
 
Total 
Perinatal 
Mortality 
Infants alive 
on 
admission 
- 2 20(1T) 14 36 
33 
IUFD 5 (1T) 3 9 7 - 
Still Birth - 1 - - - 
Neonatal 
Death - 1 4 3 - 
Infants 
Survived - 1 16 11 28 
 
Among fetuses weighing 1-1.499 kg, 3 were alive on admission 
and4 were dead in utero. Among the live foetuses of this group one 
was delivered vaginally and the same died on second day of life. The 
rest 2 were delivered by caesarean section and one of them died after 6 
hours of life. There were 4 intrauterine fetal deaths in this group. 
Among them for 3 cases Caesarean delivery was done for maternal 
indications. There were 2 stillbirths in this group and one was 
delivered vaginally and the other by caesarean section 
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In the group weighing 1500-2499 gms 27 fetuses were alive on 
admission .Among them 20 fetuses were delivered by Caesarean 
section including a twin delivery. The 7 babies delivered vaginally 
survived. Out of the 20 delivered by Caesarean section16 of them 
survived and there were 4 neonatal deaths. There were 16 IUFDs in 
this group due to severe abruption. Out of them7 could be delivered 
vaginally.9 of them were delivered by caesarean because most of them 
had a previous history of caesarean. 
In the group with birth weight more than 2500 grams there were 
44 babies .Among them 7 delivered vaginally survived. There were 3 
IUDs delivered vaginally and for 7 IUDs Caesarean section has to be 
done for maternal reasons. Among 14 babies delivered by Caesarean 
section only 11 survived. 
MATERNAL MORTALITY: 
Among the 101 cases of placental abruption, there were 2 
maternal deaths. One patient was a 22 year old G5P1A3LOwith 31 
weeks of gestation referred from another medical college with severe 
preeclampsia, bleeding p/v 2 hours duration ,placental abruption with 
absent fetal heart sounds with coagulation, liver, renal failure. She 
died within 2 hours of admission before delivery. 
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The other patient was a 30 year female, G2P1L1with a history 
of previous Caesarean section presenting at 29 weeks of gestation with 
bleeding P/V. She was delivered by Caesarean section a dead born 
female fetus of 1.6 kg after initial stabilisation of the condition. The 
admission delivery interval was1 hour. There was Couvelaire uterus at 
laparotomy but it contracted with uterotonics. There was 650 grams of 
retro placental clots. After surgery, there was bleeding from the 
surgical site and reduced renal output .Whole blood and fresh frozen 
plasma were transfused. Even after intensive care and expert 
management she died 29 hours after surgery. 
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DISCUSSION OF THE RESULTS: 
TABLE XXI 
COMPARISON OF INCIDENCE IN VARIOUS INSTITUTION 
 
Study Total No. of Cases 
No. of Cases of 
Abruption Incidence 
B.N. Purandare,33 
NowrosjeeWadia 
Maternity Hospital 
Mumbai 
80,419 518 0.63% 
VVH, Bangalore34 10,467 202 1.93% 
Present Series, IOG, 
Chennai 13,239 101 0.76% 
 
Our study has an incidence comparable to that of the study by 
B.N. Purandare’s study at Mumbai. Also the variation in incidence is 
due to the different diagnostic criteria applied for diagnoses. 
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TABLE XXII 
COMPARISON OF AGE GROUP DISTRIBUTION IN 
VARIOUS INSTITUTION 
Age Group in 
Years 
G.S. 
Mondal, 
Eden 
Hospital, 
Culcutta35 
NowrosjeeWadia 
Maternity 
Hospital, 
Mumbai33 
VVH, 
Bangalore34 
Present 
Series, 
IOG 
Chennai 
< 20 years 8.33% 10.52% 23% 6.93% 
21-25 years 44.4% 24.73% 36% 51.48% 
25-30 years 20.7% 37.36% 30% 34.65% 
31-35 years 15.7% 23.15% 9% 5.94% 
> 35years 3.72% 4.2% 2% 0.99% 
 
When age was compared the highest incidence was in the 21-25 
years age group. The reason is more number of women who delivered 
in our institute belong to this age group. Higher incidence was also 
seen in Mondol G.S. studies and VVH, Bangalore studies 
  
 65 
 
TABLE XXIII 
COMPARISON OF DISTRIBUTION OF CASES BASED ON 
PARITY 
Parity 
NowrosjeeWadia 
Maternity 
Hospital, 
Mumbai33 
VVH, 
Bangalore34 
Present Series, 
IOG Chennai 
Primi 11.57% 19.00% 38.61% 
Multi 90.41% 81% 61.38% 
 
The incidence of abruption was more in multipara than 
primipara. In the other 2 studies compared there is great increase in 
incidence in multipara. But in our study there is not too much of 
difference. Anyhow parity seems to be a risk factor 
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TABLE XXIV 
COMPARISON OF DISTRIBUTION BASED ON BOOKING 
STATUS 
Parity 
G.S. Mondal, 
Eden Hospital, 
Culcutta35 
VVH, Bangalore 
Present Series, 
IOG Chennai 
Booked 40% 5% 94.05% 
Unbooked 60% 95% 5.94% 
 
Compared to other 2 studies where unbooked cases are a 
majority. In our study booked cases account for a maximum. This is 
due to the extensive primary health care provided by our state 
government.  
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TABLE XXV 
COMPARISON OF DISTRIBUTION BASED ON 
GESTATIONAL AGE 
 
Studies 28-32 weeks 33-36 weeks 37 weeks & Above 
NowrosjeeWadia 
Maternity 
Hospital, Mumbai 
25.78% 13.68% 55.26% 
VVH, Bangalore 36% 43% 21% 
IOG, Chennai 26.73% 46.53% 26.53% 
 
Maximum incidence of abruption is seen among gestational age 
33-36 weeks. This is comparable to the study at VVH, Bangalore. 
Most of them of the late preterm group. 
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TABLE XXVI 
COMPARISON OF SIGNS & SYMPTOMS IN VARIOUS 
INSTITUTIONS 
 
Signs & 
Symptoms 
Lakshmi Ashar, 
Mumbai44 VVH, Bangalore IOG, Chennai 
Vaginal Bleeding 74.17% 85% 81.18% 
Pain Abdomen 54.26% 65% 87.12% 
Tense, Tender 
Uterus N.A. 45% 72.27% 
Absent Fetal 
Heart N.A. 66% 36.63% 
Shock 3.79% 20% 37.62% 
Hypertension N.A. 27% 61.3% 
Anaenia N.A. 80% 75.24% 
 
All3 studies show vaginal bleeding to be the most common 
presenting symptom. Hypertensive disorders seem to be the most 
common risk factor in all the 3 studies. Compared to the other two 
studies, shock was more prevalent in our study group.  
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TABLE XXVII 
 
COMPARISON OF RISK FACTORS IN VARIOUS 
INSTITUTIONS 
Signs & 
Symptoms 
Lakshmi Ashar, 
Mumbai VVH, Bangalore IOG, Chennai 
Hypertensive 
Disorders 40% 20% 61.3% 
Trauma 0.23% 1% 1.98% 
Short Cord Nil 1% 2.97% 
Hydramnios 0.47% 2% 3.96% 
Multiple 
Pregnancy Nil 5% 1.98% 
Anaemia N.A. 80% 75.24% 
 
Hypertensive disorder of pregnancy remain the most important 
contributory risk factor in all the three studies. 
The incidence of trauma was in the lower range in all three 
studies. 
Hydramnios associated with abruption was higher in our 
study.(3.96%) compared to the 2% and 0.4% seen in VVH, Bangalore 
studies and Lakshmi Ashar Mumbai studies. 
The prevalence of anaemia also seems to be comparable to that 
of the VVH, Bangalore study.  
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TABLE XXVIII 
COMPARISON BASED ON TYPES OF ABRUPTION 
 
Signs & 
Symptoms 
Lakshmi Ashar, 
Mumbai44 
VVH, 
Bangalore42 IOG, Chennai 
Mixed 66.4% 88% 76.23% 
Concealed 25.7% 2% 20.79% 
Revealed 7.9% 10% 2.97% 
 
Our study showing a higher incidence of mixed type of 
abruption (76.23%) is comparable to the incidence quoted by VVH, 
Bangalore studies (88%) and Lakshmi Ashar, Mumbai (66.4%). 
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In our study the number of vaginal deliveries was 41% and 
caesarean deliveries 59% 
Various authors have reported a caesarean section rate as follows: 
Hibbard B.M. and Jeffcoate30-8.6% 
Lakshmi Ashar, Mumbai36-0.5% 
Mudaliar A.L. and Menon-3.1% 
V.V. Hospital Bangalore34-16% 
Present IOG series-59% 
Our caesarean section rate has been high in an effort to salvage 
the fetus. Also the maternal morbidity due to caesarean has very well 
decreased now a day due to the advent of higher anbtibiotics, 
heamotological facilities. So this increased number of Caesarean 
sections has definitely brought down our maternal and perinatal 
mortality. 
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TABLE XXIX 
COMPARISON OF MATERNAL DEATHS AND PERINATAL 
DEATHS FROM VARIOUS STUDIES 
Studies Maternal Deaths Perinatal deaths 
Lakshmi Ashar36 1.6% 87.8% 
B.N. Purandare33 0.57% 79.5% 
Mondal GS35 6.48% 60.91% 
VVH, Banglore34 6% 80% 
IOG, Chennai 1.98% 48% 
 
The perinatal mortality is very low when compared to other 
studies .This may be due to the improved neonatal care in our 
institution and the timely caesarean section done to salvage the 
fetuses. 
The maternal mortality is 1.98% and is comparable to other 
institutions. This is due to delay in admissions after the occurrence of 
abruption as well the end organ damage due to severe grades of 
abruption 
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SUMMARY: 
 The incidence of APH was 191 among 13329 deliveries. 
ABRUPTIO PLACENTAE: 0.76% 
PLACENTA PREVIA: 0.5% 
OTHERS: 0.09% 
 Abruptio placentae had the highest incidence among patients 
with antepartum haemorrhage. 
 Highest incidence of placental abruption was seen between age 
group 21-25 years. The lowest age of placental abruption in our 
study was 18 years and the highest was 38 years. 
 The majority of cases were multipara compared to primi 
 Maximum incidence of abruption occurred between 33-36 
weeks of gestation. 
 Booked antenatal cases constituted the majority because of the 
increased primary health care produced by the State 
Government. 
 The predominant presenting symptom was vaginal bleeding 
followed by pain abdomen, tense, tender uterus. 
 Majority were of Grade 3 abruptions followed by Grade2 and 
Grade0. 
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 Most of the patients reported in 2-4 hours of onset of symptoms. 
This is due to the increased free transport facilities for the 
patient arranged by our Government. 
 Coagulation abnormalities were present in 23.7% of patients 
where as shock was present in 37.62%of patients. Renal failure 
was seen in3.96 % of patients. Postpartum haemorrhage was 
seen in 34.65% patients and couvelaire uterus at caesarean 
section seen in 5.94% 
 Among the vaginal deliveries 23 cases excluding Grade 0 
abruption 65.21% were delivered by ARM and Oxytocin and 
13.04% by prostaglandins and 13.04% with artificial rupture of 
membranes only. 
 41 patients had a vaginal delivery and59 patients had a 
caesarean delivery. There were only 8 neonatal deaths                
(13.55%) in babies delivered via caesarean section and one 
neonatal death following the vaginal deliveries. 
 Overall perinatal death  was 48% where in the perinatal 
mortality for vaginal delivery was41.46 % and the same for 
caesarean section was55.93% 
 Among the caesarean deliveries excluding Grade 0 cases, 
35.71% were done following an ARM and oxytocin 
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acceleration whereas 64.28 % were done directly without 
allowing for vaginal delivery. 
 There were 2 maternal deaths in our study and the 2 of them 
could have been prevented if they had earlier admission. 
 In Grade 1, 2 abruptions there were 0,2 neonatal deaths 
respectively. So the route of delivery has not influenced the 
fetal salvagability. 
 When fetal outcome was analysed by route of delivery and birth 
weight, in foetuses weighing 1500-2499 gms the fetal salvage 
by vaginal route was7/7( 100%) and that by caesarean section 
was 16/20( 80%).In those foetuses weighing more than 2500 
grams the salvagability by vaginal delivery was100% and that 
by caesarean section was11/14 78(57%). 
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CONCLUSION: 
Our study shows that abruptio placentae still represents a 
potentially serious obstetric emergency, that has an impact on 
fetalhealth, neonatal morbidity mortality as well as maternal health 
and mortality. 
 The major risk factors identified in our study are hypertensive 
disorders and anaemiain pregnancy. So management directed at 
identifying these risk factors at an earlier stage and correcting them 
will do a lot of help in reducing the incidence. 
 Majority of patients presented with Grade 3 abruption with a 
resultant intrauterine death of fetus. So early referrals from the 
peripheral institution would help to bring down the perinatal and 
maternal mortality. 
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ANNEXURES 
PROFORMA FOR EXAMINATION 
Name 
Age 
IP no 
Occupation 
Address 
Date of admission 
Date of discharge 
Socioeconomic status 
Booked/Unbooked 
Immunisation 
H/O Presenting complaints 
Period of amenorrhoea 
LMP         
EDD 
Duration of pain abdomen 
Duration of bleeding per vaginum 
H/O perception of fetal movements 
History suggestive of PIH/any medical disorders 
H/O trauma 
Other complaints 
 
  
 
Menstural History 
Age of menarche, details of menstrual cycles 
Marital History 
Obstetric History 
 
Parity index 
Last child birth 
H/O Previous pregnancy 
Past history 
Past medical/Surgical history 
Family History 
Personal History 
GENERAL EXAMINATION 
Height 
Weight 
Nourishment 
Temperature 
Cyanosis 
Pallor 
Edema 
Icterus 
Lymphadenopathy 
Pulse 
Blood Pressure 
  
 
Spine 
Breast 
Thyroid 
CVS         RS         CNS 
OBSTETRIC EXAMINATION 
Fundal height 
Abdominal Girth 
State of  uterus   Tense/not Tense 
                      Tender/not Tender 
                      Acting/not acting 
Lie,Presentation 
Fetal heart sounds 
GENITAL EXAMINATION 
Vulva 
PER SPECULAM EXAMINATION 
Amount of bleeding 
PER VAGINAL EXAMINATION 
Consistency of cervix 
Position 
Effacement 
Dilatation 
Station of head 
 
  
 
INVESTIGATIONS 
Urine routine 
Complete Haemogram 
Bleeding time,Clotting time 
Clot Observation test 
Peripheral smear 
Random blood sugar 
HIV 
HbsAg 
VDRL 
Renal function tests 
ULTRASOUND 
MANAGEMENT 
Induction/Acceleration of labour 
Method or drug used 
Mode of delivery 
Date and time of delivery 
Indication for LSCS 
Instrumental delivery 
Duration of labour 
Symptoms to delivery interval 
Complications of third stage 
 
  
 
EXAMINATION OF PLACENTA 
Presence of infarcts/calcification 
Weight of retroplacental clots 
PERINATAL OUTCOME 
Live/Stillborn/IUFD 
Term/Preterm 
Birth Weight 
APGAR 
NICU Admission: yes/no 
Condition of baby at discharge 
MATERNAL OUTCOME 
Complications during labour 
Condition of mother at discharge 
Cause of death if any 
 
 
 
 
 
 
 
  
 
 
  
 
Patient Consent Form 
Study Detail: A Study on “A CLINICAL STUDY OF 
INCIDENCE, RISK FACTORS, MATERNAL AND 
PERINATAL OUTCOME IN PREGNANCIES WITH  
ABRUPTIO PLACENTAE” 
 
Study Centre: Institute of Obstetrics & Gynaecology, Egmore,   
     Chennai-600 008 
I confirm that i have read and understood the information Sheet 
for the above study. I have had the opportunity to ask questions and all 
my questions and doubt have been answered to my complete 
satisfaction. 
I understand that my participation in the study is voluntary and 
that i am free to withdraw at an time, without giving any reason, 
without my legal rights being affected. 
I understand that the Clinical study personnel, the Ethics 
Committee and the Regulatory Authorities will not need my 
permission to look at my health records both in respect to the current 
study and any further research that may be conducted in relation to it, 
even if i withdraw from the study. I agree to this access. However, I 
Understand that my identity will not be revealed in any information 
released to third parties or published, unless as required under the law. 
I agree not to restrict the use of any data or results that arise from this 
study. 
  
 
I hereby give permission to undergo completed clinical 
examination and diagnostic tests including haematological, 
biochemical, radiological tests. 
I hereby consent to participate in this study. 
Signature/Thumb impression:.......................   Place                  Date 
of the patient 
Patient’s Name, Address & Ph.No:..................................................... 
Name of the Investigation:...................................... 
Signature of the Investigator: ......................   Place...................Date 
Institution : ................................................................ 
Signature of the Relative/Guardian............................... 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
ABBREVIATIONS 
 
LSCS Lower segment Caesarean section 
ARM Artificial rupture of membranes 
IUFD Intrauterinefetal death 
DIC Disseminated Intravascular Coagulation 
Wt Weight 
VVH Vani vilas Hospital 
APH Antepartum Haemorrhage 
Gest Gestation 
Wks Weeks 
 
 
 
 
 
 
  
 
 
 
  
 
S.N
o. 
Name Age IP NO 
Ob. 
Code 
B\UB 
G. 
Age  
(Wks
) 
Materna
l S/S 
FH 
RISK 
FACT 
Grade 
Typ
e 
Presentatio
n 
MAT. 
Compli. 
MOD 
Ab-
Del. 
Int. 
Wt. of 
RP  
Clots 
Apgar 
Score 
Baby 
wt. 
P.O M.M 
1 
RAJESWAR
I 
26 28637 primi B 38 VB+P+T + HT:A 1 M ceph _ Cs 4 150gms 7?10,8/10 3.02     
2 RATHIKA 23 29321 
G2P1
L1 
B 35 VB+P+T - HT,A 3 M ceph 
,S,CA,P
PH 
Cs 6 550gms 3/10,5/10 2.4 IUD   
3 SARITHA 22 29321 
G2P1
L1 
B 37 VB+P+T - HT+A 3 M ceph   CS 7 250gms 2/10,5/10 2.06 IUD   
4 LATHA 20 28669 PRIMI B 36 VB + A     ceph   Cs     5/10,8/10 2.12     
5 VENNILA 22 28797 primi B 36 VB + HY     TR.LIE   VAG     7/10,8/10 2.5     
6 
MAHESW
ARI 
21 28301 primi B 37 VB +       ceph   Cs     6/10,8/10 2.45     
7 DURGA 29 28672 primi B 38 VB + A     ceph   Cs     6/10,8/10 3.7     
8 VENNILA 27 30046 
G3P1
LIA1 
B 36 VB + HT+A 2 R ceph   Cs 2 500gms 2/10,3/10 2 ND   
9 
RAJESWAR
I 
23 30126 
G3P1
L1A1 
B 35 VB+P+T - HT+A 3 M ceph 
S,CA,PP
H 
VAG 6 550gms 0/10 2 IUD   
10 
HEMALAT
HA 
24 29707 
G3P1
LIA1 
B 36 VB +       OBLIQUE S Cs     4/10,7/10 3     
11 SUBHA 26 29711 primi B 31 VB   A     ceph   Cs     7/10,8/10 2.7     
12 THANGAM 27 29389 
G2P1
L1 
B 38 VB +       ceph   Cs     6/10,8/10 1.9 ND   
13 KAVITHA 21 29410 primi B 35 VB +       ceph   Cs     5/10,7/10 2.6     
14 VALLI 32 29680 primi B 36 VB + A     ceph   VAG     6/10,8/10 2.2     
15 MEERA  21 29664 
G2P1
L1 
B 37 VB +       ceph   Cs     7/10,8/10 2.4     
16 BANU 26 29680 G2A1 B 37 P -   0 C ceph   VAG   450gms 0/10 3 IUD   
17 RAMYA 25 29681 primi   32 VB+P +       ceph   VAG       3     
18 
DHANALA
KSMI 
27 29797 
G2P1
L1 
B 32 VB +       TR.LIE   Cs     6/10,7/10 1.76     
19 SUBASHINI 26 31164 
G4P2
L2A1 
B 33 VB+P+T _ 
HT+A+
RE 
0 M ceph S,PPH CS 4.5 100gms 5/10,7/10 1.8     
20 
PALAIYAT
HAL 
24 31494 
G2P1
L0 
B 36 VB+P+T _ HT+A 3 M ceph S,PPH CS 1 550gms 0/10 2.8 IUD   
21 ANNE SUJI 24 29667 primi B 21   +       ceph           2.4   
 
  
MASTER CHART 
  
 
22 
MUTHUM
ATHY 
27 31503 primi B     -I       ceph           2.8     
23 
RATHINA
M 
25 31511 primi B 35 VB + SC     ceph S VAG       2.25 IUD   
24 VIDYA 26 31524 
G2P1
L1 
B 32 VB + A     ceph   Cs             
25 MATHURI 28 31556 G2A1 B 34 VB + A     ceph   VAG             
26 Sumathy 25 31605 
G2P1
L1 
B 38 VB _   3 M ceph 
S,CA,PP
H 
VAG 2 400gms 0/10 2.25 IUD   
27 SATHYA 22 31611 G2A1 B 36 VB+P+T +   1 M ceph   Cs 3 100gms 7/10,8/10 2.25     
28 JEYAKODI 30 31540 
G2P1
L1 
B 36 VB + A     ceph   Cs             
29 
MALARKO
DI 
32 31740 primi B 37 VB + A     ceph   Cs             
30 MALAR 34 31628 
G2P1
L1 
B 37 VB + A     ceph   Cs             
31 REVATHY 25 31657 primi UB 29 VB +       ceph   Cs             
32 
ANUCHITR
A 
21 35487 PRIMI UB 29 VB+P+T - HT+A 3 M ceph 
S,CA,PP
H 
VAG 1 550gms 0/10 950 IUD   
33 LAKSHMI 28 35003 
G1P1
L1 
B 30 VB+P+T _ 
HT+T
W+A 
3 M BR,CEPH S,PPH Cs 3 600gms 0/10 
500,5
00 
BOT
HIU
D 
  
34 ANITA 27 36576 
G2P1
L1 
B 28 VB+P+T - HT+A 3 M ceph 
,S,CA,P
PH 
VAG 2 500gms 0/10 2.25 IUD   
35 RADHIKA 27 31706 primi B 34 VB + A     ceph   Cs             
36 ANSARI 25 31721 G2A1 B 36 VB + A     ceph   Cs             
37 RAMANI 24 31734 primi B 38 VB + HT     ceph   Cs             
38 SARANYA 26 35741 primi B 36 VB +       ceph   VAG             
39 AMALA 28 35756 primi B 35 VB +       ceph   Cs             
40 MENAGA 23 37946 
G2P1
L1 
B 37   + A 0 C ceph   VAG   100gms 6/10,8/10 3     
41 BHUVANA 24 37936 primi B 39 VB+T + A 2 M BR S Cs 4 200gms 5/10,7/10 3.1     
42 DIVYA 29 37950 
G2P1
L1 
B 37 VB +       ceph   Cs             
43 RADHA 32 37978 
G3P2
L2 
B 35 VB +       ceph   Cs             
 
  
 
44 PANJALI 26 37952 primi B 38   + A 0 C ceph   VAG   100gms 7/10,8/10 3.2     
45 SEETHA 24 37964 primi B 36   + A 0 C ceph   VAG   400gms 0/10 2.4     
46 SUSEELA29 25 37968 primi B 37 VB _       ceph   Cs         IUD   
47 SARADHA 26 37971 primi B 34 VB +       ceph   Cs             
48 GOMATHY 25 37864 primi B 33 VB +       ceph   Cs             
49 ARULMOZHI 22 33718 G2P1L1 B 39 VB+P+T + HT+A+RE 2 M ceph S,PPH Cs 3 200gms 4/10,6/10 3.5     
50 RAJESWARI 32 36806 G2P1L1 B 33 VB +       BR   Cs             
51 DEEPA 20 36765 G2P1L1 B 38 VB+P+T + HT+A 2 M ceph   Cs 3 200gms 5/10,7/10 2.4 AD   
52 MARY 26 31714 PRIMI B 34 VB +       ceph   CS             
53 PATTU 25 31721 G2P1L1 B 35 VB +       ceph   VAG             
54 MALATHY 26 31728 G2P1L1 B 36 P+T +       ceph   CS   100gms 6/10,7/10 2.8     
55 VASANTHA 25 31740 G2P1L1 B 37 P +       ceph   VAG   50gms 7/10,8/10 2.5     
56 DURGA 25 31748 PRIMI B 37 VB+P +       ceph   CS             
57 ELAKKIYA 26 31884 G2P1L1 B 34 VB+P+T + HT,A 2 M ceph   CS 2.5 300gms 5/10,6/10 1.7 ND   
58 MEENATCHI 21 31891 G2P1L1 B 28 VB+P+T + HT,A 2 M BR   VAG 3.5 350gms 4/10,6/10 1.2 ND   
59 GEETHA 25 31839 G2P1L1 B 38 VB +       ceph   CS             
60 SUMATHY 23 32172 G2P1L1 B 38 VB+P +   0 M ceph S VAG 3 100gms 6/10,7/10 2.9     
61 VIJAYA 26 2461 PRIMI B 30 VB _       ceph   Cs             
62 SASIREKA 28 2881 G2P1L1 B 29 VB+P+A _ A 3 M ceph S VAG 2 550gms 0/10 1 IUD   
63 BAGIYA 20 3256 PRIMI B 36 VB         ceph   Cs             
64 VANI 21 3213 primi UB 32 VB+P+T _ HT+A 3 M ceph ,,S,CA,PPH VAG 1.5 400gms 0/10 1.85 IUD   
65 VIDYA 24 3310 primi B 36 P +   0 C ceph   VAG   50gms 7/10,8/10 2.7     
66 RENGA 29 3318 primi B 34 P +   0 C ceph   VAG   100gms 6/10,8/10 1.8     
67 BHARATI 24 3325 primi B 34 VB+P +       ceph                 
68 NISHA 23 3327 primi B 37 VB+P + TW     ceph                 
 
  
 
69 BHARATI 28 3228 G3P2L2 B 35 VB+P+T - HT+A+SC 3 M ceph S,CA,PPH 
CS-
CO+HYS 
3.5 550gms 0/10 1.5 IUD   
70 JULIE 28 3332 G2P1L1 B 35 VB+P+T _ HT+HY 3 M BR S,CA,PPH Cs 4 400gms 0/10 1.8 IUD   
71 LAKSHMIDEVI 30 3479 primi B 33 VB+P+T -   3 M BR S,CA,PPH CS 5 450gms 0/10 2.8 IUD   
72 JYOTY 30 3586 G2P1L1 B 29 VB+P+T - HT+A 3 M ceph S,CA,RF,PPH CS 6 500gms O/10 750 IUD DIED 
73 SAHAYA 24 3751 primi B 34 VB+P+T +   1 R ceph   CS 4   5/10,7/10 2.5 AD   
74 MANJU  26 3820 G2P1L1 B 35 VB +       ceph   CS             
75 LAKSMI 22 3578 primi B 36 VB +       ceph   CS             
76 KALAIYARASI 26 4293 G2P1L1 B 33 VB+P+T + HT+TR 2 M ceph   CS 4 300gms 0/10 1.2 SB   
77 DHANALAKSMI 32 4435 G7P1L1A5 UB 28 VB+P+T _ HT+A 3 M ceph S,PPH CS 5 450gms 0/10 1 IUD   
78 RAMYA 27 4756 G3A2 B 32 VB+P+T +   2 M BR   CS   350gms 4/10,7/10 1.6 AD   
79 MANJULA 24 4760 G3P1L1A1 B 35 P +   0 C ceph   VAG   100gms 6/10,8/10 1.62 AD   
80 GOMATHY 23 4764 G2P1L1 B 37 P +   0 C ceph   VAG   100gms 6/10,8/10 3     
81 MADHURI 26 4781 primi B 36 VB +       ceph                 
82 AMALA 26 4787 primi B 37 VB+P +   3 M ceph   CS     6/10,8/10 2.7 IUD   
83 DHANALAKSMI 25 4857 G2A1 B 36 VB+P+t + HT+A 3 M ceph   CS 3 250gms 5/10,7/10 2.3     
84 JEEVARANI 22 5738 G3P1L1A1 B 30 VB+P+T _ HT+A 3 M BR S CS-CO 4 450gms 0/10 1.6 IUD   
85 SUGUNA 25 5918 G2P1L1 B 39 VB+P+T _ HT 3 M ceph S,CA,RF,PPH CS 6 550gms 0/10 3.2 IUD   
86 GAYATHRI 21 5932 primi B 36 VB+P+T _ HT     BR S,CA,PPH   5 550gms 0/10 1.9 IUD   
87 SHANTI 26 5922 G2A1 B 35 VB + A     ceph   CS             
88 CHITRA 31 5974 G2P1L1 B 36 VB + A     BR   CS             
89 MALAR 26 6495 primi B 37 VB+P=T _ HT,A 3 M ceph S,CA,PPH CS 4 400gms 0/10 1.5 IUD   
90 AMUL 26 6924 primi B 37 VB+P+t + HT 2 M ceph   CS 4 200gms 5/10,7/10 3.5     
91 DEVI 23 7136 G2P1L1 B 35 VB+P+T + HT+HY 1 M ceph   CS 3 100gms 6/10'8/10 3.3     
92 GIRIJA 21 7905 G2P1L1 B 36 VB+P+T + HT+A+SC 2 M ceph   CS 4 200gms 4/10,6/10 2.6 ND   
 
  
 
93 RAJAM 34 7932 G2P1L1 B 35 VB +       ceph   CS             
94 THILAKA 32 7831 primi B 34 VB + HT     ceph   CS             
95 PARVATHY 28 7965 G2A1 B 35 VB +       ceph   CS             
96 DEVI 30 7894 primi B 36 VB + A     BR   CS             
97 AZEEMA 24 8131 G2P1L0 B 35 VB+P+T _ HT+A 3 M ceph S CS 6 350gms 0/10 2.7 IUD   
98 SARANYA 25 8472 G2P1L1 B 31 VB+P+t _ HT+A 3 M BR S CS 7 600gms 0/10 1.4 IUD   
99 PRIYA 24 8476 
G3P1L1A
1 
B 36 P +   0 C ceph PPH VAG   100gms 7/10,8/10 2.6     
100 REMA 28 8480 G3P2L2 B 38 P + A 0 C ceph   VAG   50gms 6/10,7/10 2.8     
101 SAROJA 27 8489 primi B 37 P +       ceph   VAG             
102 SASIREKA 30 8479 G2P1L1 B 29 VB+P+T _ HT,A 3 M BR S,CA,RF,PPH CS 5.5 650gms 0/10 1 IUD   
103 SIVAKAMI 28 9361 G2P1L0 B 35 VB + HT     BR   CS             
104 KANAGA 26 9462 primi B 34 VB +       ceph   CS             
105 VIJALAKSMI 27 9465 G2P1L0 B 36 VB+P=T - HT,A 2 M ceph   CS 3 300gms 5/10,7/10 1.9     
106 
BALASUNDA
RI 
29 9596 G2P1L1 B 35 VB+P+T _ HT,A 1 M ceph   CS 2.5 150gms 4/10,6/10 2.5 ND   
107 MALINI 24 9261 
G3P1L1A
1 
B 32 VB+P+T + HT+A+SC 2 M TR LIE   CS 3 200gms 5/10,7/10 1.5     
108 DEVI 22 10274 G2P1L1 B 37 VB+P+T - HT,A 3 M ceph S,CA,PPH CS-CO 4 300gms 0/10 2.75 IUD   
109 JEYANTI 34 10962 G2P1L1 B 35 VB+P+T - HT 3 M ceph S,CA,PPH CS 4.5 450gms 0/10 1.95 IUD   
110 GURUSELVI 25 11033 G2P1L1 B 34 VB+P+T + HT,TW 1 M BOTHCEPH   CS 4 250gms 6/10,7/10 2.3,2.2     
111 PARIMALA 23 11964 
G3P1L1A
1 
B 32 VB+P+T - HT,HY 3 M BR S,CA,PPH CS 6 550gms 0/10 2 IUD   
112 
VIJAYALAKS
MI 
27 12011 
G5P3L1A
2 
B 32 VB+P+T + HT,A 2 M BR   CS 3.5 300gms 6/10,7/10 1.5     
113 
MANGALAKS
MI 
25 12887 G3P2L2 B 37 VB + HT     ceph S,PPH CS             
114 NITYA 26 12889 G2P1L1 B 36 P + A 0 C ceph   VAG   100gms 6/10,8/10 2.8     
115 
PALANIAMM
AL 
28 12891 primi B 37 P + A 0 C ceph   VAG   50gms 6/10,8/10 2.9     
 
  
 
116 RADHIKA 23 12911 primi B 37 P + TW     ceph   VAG             
117 SUSIMA 24 12278 primi B 38 VB + A     ceph S,PPH CS             
118 GOMATHY 28 11766 G3A2 B 33 VB + HT     ceph   CS             
119 ROSY 27 13850 primi B 37 VB+P+T + HT,A 1 M ceph   CS 3.5 200gms 6/10,8/10 2.8     
120 PUNITHA 21 15208 G2P1L1 B 35 VB+T + HT,A 2 M ceph   CS 2 350gms 6/10,7/10 1.89     
121 BHARATI 23 16717 primi B 30 VB+T - HT,A 3 M BR S,CA,PPH CS 3.5 400gms 0/10 800 IUD   
122 ABIRAMI 22 16442 primi B 38 VB +   1 M ceph   CS 3 200gms 5/10,7/10 2.6     
123 PREETHI 18 16662 primi 
U
B 
31 VB+P+T + A 2 M ceph   VAG 2.5 300gms 5/10,7/10 1.3 AD   
124 SUNITA 30 16668 primi B 38 VB+P+T - HT,A 3 M ceph S,PPH VAG 2 350gms 0/10 2.8 IUD   
125 SELVI 21 17951 primi B 35 VB+P+T + HT,HY 2 M ceph   VAG 1.5 250gms 6/10,8/10 2.6 AD   
126 DEEPA 24 18170 G2P1L1 B 33 VB+P+T - HT,A 3 M ceph S,CA,PPH VAG 1 450gms 0/10 1.7 IUD   
127 VIDYA 27 18180 G2P1L1 B 37 P +   0 C ceph   VAG   100gms 7/10,8/10 2.7     
128 RANI 28 18182 G2P1L1 B 38 P +   0 C ceph   VAG   50gms 7/10,8/10 3     
129 BRINDHA 29 18179 primi B 37 P + HT     ceph   VAG             
130 NADIYA 26 18251 G2P1L1 B 38 VB+P + A     ceph   CS             
131 SATYA 22 18224 G2A1 B 35 VB+P+T + HT,A 2 M ceph   CS-CO 3 350gms 5/10,7/10 2.25     
132 
HEMALATH
A 
24 17264 G3A2 B 34 VB +       TR LIE   CS             
133 ELIZABETH 22 18557 G2P1L1 B 29 VB+P+T + HT,A 1 M ceph   VAG 2   6/10,8/10 2.1     
134 KOKILA 23 18743 G2P1L1 B 31 VB + HT     ceph   VAG             
135 KOMALA 23 18444 G2P1L1 B 29 VB + HT     ceph   CS             
136 DEEPA 29 19266 
G3P1L1
A1 
B 35 VB +       ceph   VAG             
137 SHARMILA  22 18775 
G5P1L0
A3 
B 31 VB _ HT,A 3 M BR 
HELLP,S,CA,
RF 
          IUD DIED 
138 VASANTHI 23 19780  G2P1L1 
U
B 
29 VB - HT,A 3 M ceph S,CA,PPH CS 3.5 250gms 0/10 2.75 IUD   
139 PUNITHA 28 20634 G2P1L1 B 37 VB+P+T - HT,A 3 M ceph S,CA,PPH CS 5 350gms 0/10 1.5 IUD   
 
  
 
140 MARIAMMAL 23 21173 G2A1 B 31 VB+P+T + HT,A 3 M ceph   CS   100gms 5/10,7/10 2.8     
141 ANSARI 26 21176 G3P2L2 B 36 P + A 0 C ceph   VAG   100gms 6/10,8/10 3     
142 KALYANI 22 21182 G2P1L1 B 38 P + A 0 C ceph   VAG             
143 SANKARI 26 21190 primi B 37 P + HT     ceph   VAG             
144 VINODHINI 24 21187 primi B 36 P + HT     ceph   CS             
145 THANGAM 20 21189 primi B 37 VB+P + HT     ceph   CS             
146 PATTU 27 21195 G2P1L1 B 35 VB+P +       ceph   CS             
147 AGALYA 21 21659 primi B 32 VB+P+T + HT,A 2 M ceph S,PPH CS 7 250gms 3/10,5/10 1.7 ND   
148 SATYA 22 21744 primi B 34 VB+P+T + HT,A 1 M ceph   CS 3 150gms 5/10,7/10 2.8     
149 THENMOZHI 31 22392 G2P1L1 B 35 VB+P+T + HT,A 1 R ceph   CS 4 200gms 6/10,8/10 2.23     
150 NAZIN 18 24342 primi B 36 VB+P+T - HT,A 3 M ceph S,CA,PPH CS-CO 8 650gms 0/10 2 IUD   
151 BASHEERUNISA 35 24709 G4P1L1A2 B 34 VB+P+T + A 2 M ceph   CS 3.5 200gms 5/10,7/10 1.9 AD   
152 ADHILAKSMI 20 24905 primi B 34 VB+P+T + HT,A 2 M TR LIE   CS 2 250gms 6/10,8/10 1.9 AD   
153 PREMA 24 25261 primi B 29 VB+P+T - HT,A 3 M ceph S,CA,PPH CS-CO 5.5 400gms 0/10 2.5 IUD   
154 VIJAYA 20 25744 primi B 35 VB+P+T + HT,A 1 M ceph   CS 3 250gms 6/10,7/10 1.8 ND   
155 ESWARI 25 23698 G4P1L1A2 B 30 VB + HT     ceph   CS             
156 REMADEVI 26 25829 G2P1L1 B 38 VB + HT     ceph   CS             
157 BHUVANA 25 25832 G2P1L1 B 36 P +   0 C ceph   VAG   100gms 6/10,7/10 2.6     
158 RAMYA 32 25840 G3P2L2 B 37 P + A 0 C ceph   VAG   50gms 6/10,7/10 2.8     
159 VIJI 33 25860 primi B 37 VB+P + A     ceph   CS             
160 RAGHAVI 28 25849 G2A1 B 37 VB + A     ceph S,PPH CS             
161 KAMALA 25 25832 primi B 36 VB+P +       ceph   CS             
162 PRIYA 27 26429 G2P1L1 B 36   + HT,A     ceph S,PPH CS             
163 VENMATHI 38 26496 primi B 32 VB+P+T + HT,A 2 M ceph   CS 2 250gms 5/10,7/10 1.48     
164 PRAVEENA 27 26429 G2P1L1 B 34 VB+P+T + A 2 M ceph   CS 3 300gms 6/10,8/10 1.5     
165 SAAIKALA 19 26431 primi UB 30 VB+P=T + A 2 M ceph   VAG 6 350gms 0/10 1.3 SB   
  
 
166 ARUNA 22 26512 G2P1L1 B 35 VB + A+RE 2 M ceph   VAG 5 200gms 4/10,7/10 2.2     
167 RENUKA 32 26332 G3P2L2 B 36 VB + HT     ceph    VAG             
168 RANI 27 26351 G2P1L1 B 34 VB + HT     BR    CS             
169 VANAJA 26 26361 G3P2L1 B 35 VB + HT     ceph    VAG             
170 KANMONI 26 26490 G2A1 B 36 VB +       ceph    CS             
171 VENDA 23 26481 G3P2L2 
U
B 
36 VB+P+T + A 2 M ceph   VAG 4 250gms 5/10,7/10 2.4     
172 AMMU 24 26516 G2P1L1 B 35 VB + A 2 M ceph   VAG 3 200gms 5/10,7/10 2.2     
173 SHAKILA 26 26520 G3P1L1A1 
U
B 
34 VB +       ceph   CS             
174 RUKKU 32 26528 G2P1L1 B 35 VB +       ceph   CS             
175 BAGLAKSMI 25 26501 primi B 37 VB +       ceph   CS             
176 DEVAGI 24 26534 primi B 36 VB + HT     ceph   CS             
177 PRABHA 23 26540 primi B 36 VB +       ceph   CS             
178 VEENA 27 26531 primi B 37 VB +       ceph   CS             
179 SRIDEVI 26 26539 G2P1L1 B 36 VB+P +       BR   CS             
180 AKILA 25 26541 G3A2 B 35 VB+P + HT     ceph   VAG             
181 PADMA 23 26550 G2A1 B 38 VB +       ceph   CS             
182 SASIREKA 21 26559 primi B 36 VB +       ceph   CS             
183 VIMALA 26 26487 primi B 34 VB+P+T + HT,A 2 M ceph   CS 4 200gms 6/10,7/10 2.1     
184 AMBUJAM 24 26570 G2P1L1 B 35 VB+P+T + A 2 M ceph   CS 3.5 150gms 5/10,7/10 2.2     
185 RAJESWARI   26556 G2P1L1 B 35 VB + HT     ceph   CS             
186 ELIZABETH 22 31620 G2P1L1 B 32 VB +P+T + HT+TR 1 M ceph   VAG 2 250gms 6/10,8/10 2.1     
187 SUGUNA 25 31711 primi B 39 VB+P+T _+ HT,A 2 M ceph   VAG 3 250gms 6/10,8/10 2.6     
188 USHA 28 31690 G4P2L1A1 B 36 VB+P+T _   3 M ceph S,CA,PPH VAG 2 600gms 2/10,3/10 800 IUD   
189 RANJANI 23 31710 G2A1 B 35 P+T +   0 C ceph   VAG   100gms 7/10,8/10 2     
190 REKHA 20 31724 G3P2L2 B 36 VB+P+T - HT,A 3 M ceph S,PPH VAG 2 400gms 0/10 1.5 IUD   
191 DEEPA 30 31740 G3P1L1A1 B 32 VB+P+T +   1 M ceph   CS 2.5 250gms 6/10,7/10 1.6 AD   
  
 
KEY TO MASTER CHART 
Ob.Code : Obstetric Code 
B : Booked 
UB : Unbooked 
G.Age : Gestational Age 
Wks : weeks 
S/S : Signs,symptoms 
FH : Fetal heart 
Risk Fact : Risk Factors 
MAT Compli:  Maternal complications 
S : Shock 
CA : Coagulation abnormality 
PPH : Postpartum Haemorrhage 
SC : Short cord 
RE : Recurrence 
RF : Renal failure 
TW : Twins 
M : Mixed 
C : Concealed 
R : Revealed 
TR : Trauma 
HY : Hydramnios 
VB : Vaginal bleeding 
  
 
P : Pain abdomen 
T : Tense tender uterus 
M.O.D : Mode of Delivery 
Ab-Del-Int : Abruption delivery interval 
Ceph. : cephalic 
BR : breech 
TR lie : Transverse lie 
HT : Hypertension 
A : Anaemia 
Wt : weight 
RP clots : Retroplacental clots 
P.O : perinatal outcome 
M.M : Maternal mortality 
IUD : Intra uterine fetal death 
ND : Neonatal death 
AD : Admission 
Cs : Caesarean section 
VAG : Vaginal delivery 
 
